首页> 外国专利> Compound 2-amine-8-(4-methyl-pyridine-1-carbon) -4-phenylenediene 1,2-D pyridine-5-ona, target country of adenosine-A2A receptor; drug synthesis; and the production of medicines for the treatment or prevention of neurodegenerative diseases (such as incidental diseases) Ginson, Alzheimer's, etc.

Compound 2-amine-8-(4-methyl-pyridine-1-carbon) -4-phenylenediene 1,2-D pyridine-5-ona, target country of adenosine-A2A receptor; drug synthesis; and the production of medicines for the treatment or prevention of neurodegenerative diseases (such as incidental diseases) Ginson, Alzheimer's, etc.

机译:化合物2-胺-8-(4-甲基吡啶-1-碳)-4-苯二烯[1,2-D]吡啶-5-ona,腺苷-A2A受体的靶标国家;药物合成以及用于治疗或预防神经退行性疾病(例如偶然疾病)金森,阿尔茨海默氏病等的药物的生产

摘要

Compound 2 - amino - 4 - (4 - methyl - 1 - piperazine carbonyl) - 4 - phenyl - indeno [1,2-d] pyrimidine 5 - ona, a2ade adenosine receptor antagonist,Pharmaceutical composition containing same and their use in Neurodegenerative Disorders or Movement, such as Parkinson's disease, Huntington's, Alzheimer's and Dementia, among others.
机译:化合物2-氨基-4-(4-甲基-1-哌嗪羰基)-4-苯基-茚并[1,2-d]嘧啶5 -ona,腺苷腺苷受体拮抗剂,包含其的药物组合物及其在神经退行性疾病中的用途或运动,例如帕金森氏病,亨廷顿氏病,阿尔茨海默氏病和痴呆症等。

著录项

  • 公开/公告号CL2008003131A1

    专利类型

  • 公开/公告日2010-02-19

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA N.V.;

    申请/专利号CL20080003131

  • 发明设计人 SHOOK BRIAN C.;JACKSON PAUL F.;

    申请日2008-10-23

  • 分类号A61K31/496;A61K31/517;A61P25/00;A61P25/16;A61P25/24;A61P25/28;A61P25/30;C07D239/70;C07D241/04;C07D403/10;A61P25/222;

  • 国家 CL

  • 入库时间 2022-08-21 18:47:16

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号